Limited ERG11 Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Limited ERG11 Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 10, Pages -
Publisher
American Society for Microbiology
Online
2018-08-01
DOI
10.1128/aac.01427-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates
- (2018) Cosmeri Rizzato et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance
- (2018) Anuradha Chowdhary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris
- (2018) Johanna Rhodes et al. Emerging Microbes & Infections
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase
- (2015) Alia A. Sagatova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms andIn VivoImpact in Infected Galleria mellonella Larvae
- (2015) Ana Carolina R. Souza et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Clinically Derived Mutations inERG11to Azole Resistance in Candida albicans
- (2014) Stephanie A. Flowers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System
- (2014) Nina T. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanisms of Antifungal Drug Resistance
- (2014) Leah E. Cowen et al. Cold Spring Harbor Perspectives in Medicine
- Erg11mutations associated with azole resistance in clinical isolates ofCandida albicans
- (2013) Ming-Jie Xiang et al. FEMS YEAST RESEARCH
- Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
- (2012) C. Jiang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CRS-MIS inCandida glabrata: sphingolipids modulate echinocandin-Fks interaction
- (2012) Kelley R. Healey et al. MOLECULAR MICROBIOLOGY
- Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
- (2010) Florent Morio et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations
- (2008) Y. Xu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started